ORIGINAL ARTICLE

Characteristic gynaecology-oncology patients from Obstetrics and Gynaecology Outpatient Clinic Mangusada Regional Hospital Badung reffered to Sanglah Hospital from 1st January 2016 – 31st December 2018

Bagus Ngurah Brahmantara , Ida Bagus Made Kartha, I Nyoman Gede Budiana

Bagus Ngurah Brahmantara
Obstetrics and Gynaecology Departement, Mangusada Hospital Badung, Bali-Indonesia. Email: dr.brahmantara11@gmail.com

Ida Bagus Made Kartha
Obstetrics and Gynaecology Departement, Mangusada Hospital Badung, Bali-Indonesia

I Nyoman Gede Budiana
Obstetrics and Gynaecology Departement, Faculty of Medicine, Universitas Udayana, Sanglah Hospital, Bali-Indonesia
Online First: August 01, 2020 | Cite this Article
Brahmantara, B., Kartha, I., Budiana, I. 2020. Characteristic gynaecology-oncology patients from Obstetrics and Gynaecology Outpatient Clinic Mangusada Regional Hospital Badung reffered to Sanglah Hospital from 1st January 2016 – 31st December 2018. Bali Medical Journal 9(2): 430-436. DOI:10.15562/bmj.v9i2.1836


Background: Every year, there is an increase in malignancy cases in the world. In women, malignancy is the second most cause of death. Gynecologic malignancy can be found in all women reproductive tract, including cervix, ovary, uterus, vagina and vulva. Most women death from gynecologic malignancy occurred in developing countries, and this is due to lack of access for early detection and treatment. The study aims to report characteristic of patients referred from Obstetrics and Gynaecology Outpatient Clinic Mangusada Hospital, Badung from January 2016 – December 2018.

Results: Total referred case were 451 gynaecology-oncology patients in obstetrics and gynaecology outpatient clinic Mangusada Hospital, Badung-Indonesia. Top three most referred case were cervical cancer, ovarian cyst with malignancy suspected and ovarian cancer. For Cervical cancer, most of the patients are in group age 41-50 years old (40,3%), in-stadium III (59,2%) and squamous cell type (71,7%). For ovarian cancer, most of the patients are in group age 41-50 years old (45,1%), in-stadium III (59,2%), and epithelial type cell (87,3%). For endometrial cancer, most of the patients are in group age 51-60 years old (53,9%), in-stadium III (46,1%) and adenocarcinoma cell type (100%).

Conclusion: The most common gynaecological referral cases are cervical cancer, suspicious malignant ovarian cysts, and ovarian cancer. All gynaecological cases referred to are suspected or diagnosed as gynaecological malignancies and require the handling of a gynaecology-oncology division and integrated oncology services.

References

Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics 2014. CA Cancer J Clin. 2014; 64: 9-29.

Barman D, Sharma JD, Barmon D, Kataki AC, Sharma A, Kalita M. Epidemiology of Gynecological Cancers in Kamrup Urban District Cancer Registry. Indian Journal of Cancer. 2017;54:388-391.

SEER Cancer Statistics Factsheets: Cervix Uteri Cancer. National Cancer Institute. Bethesda, MD

Aziz MF. Gynecological Cancer in Indonesia. Journal Gynecology Oncology. 2002; 20:1-6.

Mahendra INB. The Characteristic of Cervical Cancer Patients who underwent a Radical Hysterectomy at Sanglah Hospital Denpasar in 2015. Bali Medical Journal, 2016;5(1):48-50.

Dewi PPD, and Budiana ING. Characteristics of endometrial cancer in Sanglah Hospital period August 2012 – July 2014. E-Jurnal Medika. 2017;6:8-15.

Prabasari CIW, Budiana ING. Profile of cervical cancer patient in Sanglah General Hospital from July 2012 to June 2013. E-Jurnal Medika. 2017;6:8-14.

Prandana DA, Rusda M. Cervical cancer profile in H. Adam Malik General Hospital, Medan in 2011. E-Jurnal FK USU. 2013;1:2-8.

Watulingas AM, Loho M, Wagey F. Characteristics of cervical cancer patient in Prof. dr. R. D. Kandou Manado from 1st January 2013 – 31st December 2015. Jurnal e-clinic. 2016;4:2-8.

Fajriah R. Characteristic of histology findings in cervical cancer patient at Dr. Zainoel Abidin General Hospital, Banda Aceh. Syiah Kuala Medical Jurnal. 2013; 13:1-8.

Hacker NF, Vermoken JB. Cervical Cancer. In: Practical Gynecologic Oncology. Philadelphia USA: Lippincott Williams & Wilkins, 2005; p. 326-30.

Seppa K, Pitkaniemi J, Malila N, Hakaya M. Age related incidence of cervical cancer support two etiological components: a population base register study. 2016;123:772-78.

Clay JM, Daggy JK, Fluellen S, Edmonds BT. Patient Knowledge and Attitudes Toward Cervical Cancer Screening after the Screening Guidelines. Patient Education and Counseling. Patient education and counselling. 2018;102: 411-15.

Nuranna L, Prastasari R, Sutrisna B. Survival of Cervical Cancer Patients and Its Prognostic Factors at Cipto Mangunkusumo Hospital Jakarta. Medical Journal Indonesia. 2014;23:3-9.

Haryani S, Defrin Y. Prevalence of cervical cancer based on parity at Dr. M. Djamil Hospital from January 2011- December 2012. Jurnal Kesehatan Andalas. 2016;5:3-10.

Herlana F, Nur IM, Purbaningsih W. Characteristics of cervical cancer patient based on age, parity, and histology findings in Al-Ihsan Hospital Bandung. Bandung Meeting on Global Medicine and Health. 2017.

Dhitayoni IA, Budiana ING. Profile of ovarian cancer in Sanglah General Hospital from July 2013 - June 2014. E-Jurnal Medika. 2017;6:3-10.

Sinaga LRV, Lumbantoruan MR. Characteristics of ovarian cancer patient in Pringadi Hospital from 2012-2016. Wahana Inovasi. 2018;7:2-9.

Gong TT, Wu J, Vogtmann, Lin B. Age at menarche and risk of ovarian cancer: a meta-analysis of epidemiological studies. Int J Cancer. 2014;132:2893-900.

Hankinson SE, Danforth KN. Ovarian cancer. In: Schottenfeld D, Fraumeni J, editors. Cancer epidemiology and prevention. 3. New York, NY: Oxford University Press; 2006. p. 1013–26.

Doubeni CA, Doubeni AR, Myers AE. Diagnosis and management of ovarian cancer. Am Fam Physician. 2016;93:937-44.

Arania R, Windarti I. Characteristics of ovarian cancer in Dr. H. Abdul Moeloek Hospital in 2009-2013. Juke Unila. 2015;5:9-13.

Schorge JO, Schaffer JI, Hoffman BL, Bradshaw KD, Cunningham FG. Epithelial Ovarian Cancer in Williams Gynecology. New York: McGraw-Hill. 2008. 716-20.

Tulumang JA, Loho MF, dan Mamengko LM. Characteristics of endometrial cancer in Prof. Dr. R. D. Kandou Hospital from 2013- 2015. Jurnal e-clinic, 2016;4:1-8.

Pradjatmo H, Pahlevi DP. Nutritional status as a prognostic for endometrial cancer. Jurnal Gizi Klinik Indonesia. 2013;1:10-16.

Renaud MC. Epidemiology and investigations for suspected endometrial cancer. JOGC. 2018;40(9):703-11.

Albeesh R, Turgeon GA, Alferi J, Jose M, Fu L. Adjuvant therapy in stage III endometrial cancer confined to the pelvis. Gynecologic Oncology. 2019;152(1):26-30.

Cornel KMC, Bongers MY, Kruitwagen RPF, Romano A. Local estrogen metabolism in endometrial cancer: A Systematic review. Molecular and Cellular Endocrinology. 2019;489:45-66.


No Supplementary Material available for this article.
Article Views      : 0
PDF Downloads : 0